— Elise Hebb left Seattle-based venture capital firm Maveron, where she was COO and partner, and is planning to launch a consulting firm next year. Hebb, who joined Maveron in… Read More
Seattle-based Aptevo Therapeutics completed a spinoff from Emergent BioSolutions Monday, making a debut in the public markets as a standalone company. They are the second Seattle-area biotech company to go public… Read More